Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Osteosarcoma is the most common primary bone cancer affecting children and adolescents worldwide. Despite an incidence of three cases per million annually, it accounts for an inordinate amount of morbidity and mortality. While the use of chemotherapy (cisplatin, doxorubicin, and methotrexate) in the last century initially resulted in marginal impro...
Alternative Titles
Full title
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8f1e2e55df274950b74046abcf7a2849
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8f1e2e55df274950b74046abcf7a2849
Other Identifiers
ISSN
1756-8722
E-ISSN
1756-8722
DOI
10.1186/s13045-016-0373-z
